1. Home
  2. NOTV vs BDSX Comparison

NOTV vs BDSX Comparison

Compare NOTV & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.80

Market Cap

29.9M

Sector

Health Care

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$7.79

Market Cap

53.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTV
BDSX
Founded
1974
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9M
53.0M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
NOTV
BDSX
Price
$0.80
$7.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$3.00
$32.50
AVG Volume (30 Days)
1.6M
57.5K
Earning Date
12-03-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$513,024,000.00
$80,173,000.00
Revenue This Year
$6.26
$20.75
Revenue Next Year
$45.49
$25.05
P/E Ratio
N/A
N/A
Revenue Growth
4.54
22.29
52 Week Low
$0.66
$3.44
52 Week High
$6.48
$32.20

Technical Indicators

Market Signals
Indicator
NOTV
BDSX
Relative Strength Index (RSI) 36.67 51.69
Support Level $0.84 $7.68
Resistance Level $0.95 $8.17
Average True Range (ATR) 0.12 0.66
MACD 0.02 0.02
Stochastic Oscillator 39.36 55.68

Price Performance

Historical Comparison
NOTV
BDSX

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: